1. Home
  2. SNT vs PLRX Comparison

SNT vs PLRX Comparison

Compare SNT & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Senstar Technologies Ltd.

SNT

Senstar Technologies Ltd.

N/A

Current Price

$2.55

Market Cap

64.6M

ML Signal

N/A

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.15

Market Cap

74.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNT
PLRX
Founded
1965
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.6M
74.9M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
SNT
PLRX
Price
$2.55
$1.15
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$2.67
AVG Volume (30 Days)
39.8K
495.8K
Earning Date
04-23-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.97
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.29
$1.09
52 Week High
$5.34
$1.95

Technical Indicators

Market Signals
Indicator
SNT
PLRX
Relative Strength Index (RSI) 34.53 43.49
Support Level N/A $1.14
Resistance Level $2.87 $1.37
Average True Range (ATR) 0.16 0.05
MACD -0.02 0.00
Stochastic Oscillator 12.69 17.86

Price Performance

Historical Comparison
SNT
PLRX

About SNT Senstar Technologies Ltd.

Senstar Technologies Corp is an international provider of comprehensive physical, video, and access control security products and solutions. The company offers comprehensive solutions for critical sites, which leverage its broad portfolio of homegrown PIDS (Perimeter Intrusion Detection Systems), advanced VMS and SMS (Video Management Software and Security Management Software) with native IVA (Intelligent Video Analytics) security solutions, as well as access control products and technologies. Geographically, the company operates in North America, which derives maximum revenue; Europe; APAC; South and Latin America; and Others.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: